This Article Full Text Full Text (PDF) Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a colleague Related articles in JOP Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                            What's this?

ASCO's Legislative Conference: NCI, FDA, and CMS Outline Projects to Enhance the Quality of Cancer Care

Leaders of the top three federal agencies that deal with the cancer problem spoke at ASCO's July Legislative Conference, and all organized their remarks around the theme of collecting, paying for, and acting on the wealth of data they currently have or will acquire. Centers for Medicare & Medicaid Services (CMS) Administrator Mark McClellan, MD, PhD, Director of the National Cancer Institute (NCI) and acting Commissioner of the U.S. Food and Drug Administration (FDA) Andrew von Eschenbach, MD, and former Commissioner of the FDA Lester Crawford, DVM, PhD, all delivered formal remarks on July 26, 2005.

	CMS, the Oncology Demonstration Project, and Benefit Updates

 
Most oncologists are familiar . . . [Click for More]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Related articles in JOP:

Douglas W. Blayney
JOP 2006 2: 1. [Extract] [Full Text]